81_FR_23072 81 FR 22997 - National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting

81 FR 22997 - National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 75 (April 19, 2016)

Page Range22997-22997
FR Document2016-08994

Federal Register, Volume 81 Issue 75 (Tuesday, April 19, 2016) 
[Federal Register Volume 81, Number 75 (Tuesday, April 19, 2016)]
[Notices]
[Page 22997]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-08994]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Biomedical Imaging and Bioengineering; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Biomedical Imaging and 
Bioengineering Special Emphasis Panel; NIBIB P41 Site Visit (2016/
10).
    Date: May 1-3, 2016.
    Time: 6:00 p.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Dallas Marriott Suites Medical/Market Center, 2493 North 
Stemmons Freeway, Dallas, TX 75207.
    Contact Person: Ruixia Zhou, Ph.D., Scientific Review Officer, 
6707 Democracy Boulevard, Democracy Two Building, Suite 967, 
Bethesda, MD 20892, (301) 496-4773, [email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.


    Dated: April 13, 2016.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-08994 Filed 4-18-16; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 75 / Tuesday, April 19, 2016 / Notices 22997 Bethesda, MD 20892–2542, (301) 594–8898, MSC 7892, Bethesda, MD 20892, 301–435– DEPARTMENT OF HEALTH AND barnardm@extra.niddk.nih.gov. 2902, filpuladr@mail.nih.gov. HUMAN SERVICES (Catalogue of Federal Domestic Assistance (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Program Nos. 93.306, Comparative Medicine; National Institutes of Health Endocrinology and Metabolic Research; 93.333, Clinical Research, 93.306, 93.333, 93.848, Digestive Diseases and Nutrition 93.337, 93.393–93.396, 93.837–93.844, National Institute of Biomedical Research; 93.849, Kidney Diseases, Urology 93.846–93.878, 93.892, 93.893, National Imaging and Bioengineering; Notice of and Hematology Research, National Institutes Institutes of Health, HHS) Closed Meeting of Health, HHS) Dated: April 13, 2016. Dated: April 13, 2016. David Clary, Pursuant to section 10(d) of the Federal Advisory Committee Act, as David Clary, Program Analyst, Office of Federal Advisory Committee Policy. amended (5 U.S.C. App.), notice is Program Analyst, Office of Federal Advisory hereby given of the following meeting. Committee Policy. [FR Doc. 2016–08991 Filed 4–18–16; 8:45 am] The meeting will be closed to the [FR Doc. 2016–08996 Filed 4–18–16; 8:45 am] BILLING CODE 4140–01–P public in accordance with the BILLING CODE 4140–01–P provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., DEPARTMENT OF HEALTH AND as amended. The grant applications and DEPARTMENT OF HEALTH AND HUMAN SERVICES the discussions could disclose HUMAN SERVICES confidential trade secrets or commercial National Institutes of Health National Institutes of Health property such as patentable material, National Institute of Allergy and and personal information concerning Center for Scientific Review; Notice of Infectious Diseases; Notice of Closed individuals associated with the grant Closed Meetings Meeting applications, the disclosure of which would constitute a clearly unwarranted Pursuant to section 10(d) of the Pursuant to section 10(d) of the invasion of personal privacy. Federal Advisory Committee Act, as Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is Name of Committee: National Institute of amended (5 U.S.C. App.), notice is Biomedical Imaging and Bioengineering hereby given of the following meetings. hereby given of the following meeting. Special Emphasis Panel; NIBIB P41 Site Visit The meeting will be closed to the (2016/10). The meetings will be closed to the public in accordance with the public in accordance with the Date: May 1–3, 2016. provisions set forth in sections Time: 6:00 p.m. to 12:00 p.m. provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., Agenda: To review and evaluate grant 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and applications. as amended. The grant applications and the discussions could disclose Place: Dallas Marriott Suites Medical/ the discussions could disclose confidential trade secrets or commercial Market Center, 2493 North Stemmons confidential trade secrets or commercial Freeway, Dallas, TX 75207. property such as patentable material, property such as patentable material, Contact Person: Ruixia Zhou, Ph.D., and personal information concerning Scientific Review Officer, 6707 Democracy and personal information concerning individuals associated with the grant Boulevard, Democracy Two Building, Suite individuals associated with the grant applications, the disclosure of which 967, Bethesda, MD 20892, (301) 496–4773, applications, the disclosure of which would constitute a clearly unwarranted zhour@mail.nih.gov. would constitute a clearly unwarranted invasion of personal privacy. This notice is being published less than 15 invasion of personal privacy. days prior to the meeting due to the timing Name of Committee: National Institute of Name of Committee: Center for Scientific Allergy and Infectious Diseases Special limitations imposed by the review and Review Special Emphasis Panel; Great Emphasis Panel; ‘‘NIAID Investigator funding cycle. Challenge Synthetic Biology Program Project. Initiated Program Project Applications (P01)’’ Date: May 19–20, 2016. Dated: April 13, 2016. Date: May 12, 2016. Time: 8:00 a.m. to 5:00 p.m. Time: 11:00 a.m. to 5:00 p.m. David Clary, Agenda: To review and evaluate grant Agenda: To review and evaluate grant Program Analyst, Office of Federal Advisory applications. applications. Committee Policy. Place: National Institutes of Health, 6701 Place: National Institutes of Health, Room [FR Doc. 2016–08994 Filed 4–18–16; 8:45 am] Rockledge Drive, Bethesda, MD 20892 3F100, 5601 Fishers Lane, Rockville, MD BILLING CODE 4140–01–P (Virtual Meeting). 20892, (Telephone Conference Call). Contact Person: Sergei Ruvinov, Ph.D., Contact Person: Jay R. Radke, Ph.D., Scientific Review Officer, Center for Scientific Review Officer, Scientific Review Scientific Review, National Institutes of Program, Division of Extramural Activities, DEPARTMENT OF HEALTH AND Health, 6701 Rockledge Drive, Room 4158, Room #3G11B, National Institutes of Health, HUMAN SERVICES MSC 7806, Bethesda, MD 20892, 301–435– NIAID, 5601 Fishers Lane MSC–9823, 1180, ruvinser@csr.nih.gov. Bethesda, MD 20892–9823, (240) 669–5046, National Institutes of Health jay.radke@nih.gov. Name of Committee: Center for Scientific Prospective Grant of Exclusive Review Special Emphasis Panel; PAR Panel: (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, License: The Development of MRI– High Throughput Screening. Date: May 19, 2016. and Transplantation Research; 93.856, 1569, MRI–2213 and MRI–2214 as a Time: 8:00 a.m. to 6:00 p.m. Microbiology and Infectious Diseases Therapeutic To Treat Obesity, mstockstill on DSK4VPTVN1PROD with NOTICES Agenda: To review and evaluate grant Research, National Institutes of Health, HHS) Diabetes, Fatty Liver Disease and Liver applications. Dated: April 14, 2016. Fibrosis Place: Residence Inn Bethesda, 7335 Natasha M. Copeland, Wisconsin Avenue, Bethesda, MD 20814. AGENCY: National Institutes of Diabetes Contact Person: David Filpula, Ph.D., Program Analyst, Office of Federal Advisory and Digestive and Kidney Diseases, Scientific Review Officer, Center for Committee Policy. Public Health Service, PHS, National Scientific Review, National Institutes of [FR Doc. 2016–08993 Filed 4–18–16; 8:45 am] Institutes of Health, Department of Health, 6701 Rockledge Drive, Room 6181, BILLING CODE 4140–01–P Health and Human Services. VerDate Sep<11>2014 18:02 Apr 18, 2016 Jkt 238001 PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 E:\FR\FM\19APN1.SGM 19APN1


Document Created: 2016-04-19 00:16:16
Document Modified: 2016-04-19 00:16:16
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesMay 1-3, 2016.
FR Citation81 FR 22997 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR